including Huntington's disease. Molecular chaperones modulate the aggregation and toxicity of the huntingtin (Htt) protein by an ill-defined mechanism. Here we determine how the chaperonin TRiC suppresses Htt aggregation. Unexpectedly, TRiC does not physically block the polyQ tract itself, but rather sequesters a short Htt sequence element, N-terminal to the polyQ tract, that promotes the amyloidogenic conformation. The residues of this element essential for rapid Htt aggregation are directly bound by TRiC. Our findings illustrate how molecular chaperones, which recognize hydrophobic determinants, can prevent aggregation of polar polyQ tracts associated with neurodegenerative diseases. The observation that short endogenous sequence elements can accelerate the switch of polyQ tracts to an amyloidogenic conformation provides a novel target for therapeutic strategies.
a r t i c l e s Expansion of polyglutamine (polyQ) repeats beyond a critical threshold has been linked to protein toxicity in a number of neuro degenerative disorders, including Huntington's disease 1, 2 . These expanded polyQ repeat proteins aggregate through both intra and intermolecular interactions between polyQ stretches, ultimately leading to the formation of fibrillar βsheetrich amyloid inclusions associated with neuronal dysfunction and death [3] [4] [5] [6] [7] . Although there is a clear correlation between polyQ length and disease onset and sever ity, a number of observations suggest that aggregation is profoundly influenced by factors outside the polyQ tract. Thus, the clinical course of disease can vary widely in patients with identical polyQ repeat lengths 8 . Furthermore, several cellular proteins contain long polyQ tracts, but few trigger neurological disorders. Intriguingly, ataxin3 remains soluble and nonpathogenic at polyQ lengths well above 50 glutamines 1 , whereas huntingtin is pathogenic above a threshold of 35 glutamines. These observations raise the question of how context influences the behavior of the expanded polyQ tract 9, 10 .
The intrinsic and extrinsic factors other than polyQtract length that modulate polyQ aggregation in the cell are not well understood. Studies using huntingtin exon 1 (Httexon1), a naturally occurring proteolytic fragment of Htt that is responsible for Huntington's disease (HD) patho genesis, indicate that the prolinerich domain (PRD) Cterminal to the polyQ tract attenuates its aggregation and subsequent toxicity 9, [11] [12] [13] .
Aggregation is also influenced by the cellular environment [14] [15] [16] . Molecular chaperones are important modulators of aggregation and toxicity of polyQexpanded proteins in the cell. In particular, the heterooligomeric chaperonin TRiC, also called CCT, was recently identified as a potent suppressor of Htt aggregation and toxicity [17] [18] [19] . An intriguing question raised by these studies is how chaperones, which generally recognize exposed hydrophobic regions in nonnative proteins, can prevent aggregation of the highly polar polyQ stretch.
TRiC is a ringshaped, heterooligomeric chaperonin that uses cycles of ATP binding and hydrolysis to bind unfolded polypeptides and facilitate their folding 20, 21 . Recent work indicates that individ ual subunits differ in their recognition specificity 22 . Indeed, TRiC suppression of Httexon1 aggregation is mediated by interactions between specific TRiC subunits, primarily subunit 1 (also called CCT1 or TCP1) and to a lesser extent subunit 4 and early amy loid aggregate precursors 18, 19 . However, the mechanism by which TRiC and other molecular chaperones suppress polyQ aggrega tion remains to be defined. In the simplest model, TRiC and other chaperones would block aggregation by shielding the polyQ tract, similar to their role in preventing aggregation of other unfolded polypeptides 10, 21, 23 . However, this model presents several prob lems. First, TRiC, like other chaperones, appears to preferentially recognize hydrophobic sequences 22 , whereas the polyQ tract is primarily polar 24 . Additionally, because ATPase cycling leads to substrate release, and the polyQ tract is inherently aggregation prone 3, 25 , the simple shielding model also raises the question of why aggregation does not occur upon ATPinduced Htt release during a r t i c l e s chaperonin cycling, as in these conditions the natively unfolded polyQ tract is released again to the cellular milieu.
Here we investigate the molecular basis of the HttTRiC interaction and elucidate how it can prevent aggregation in human cells. We dem onstrate that TRiC suppresses pathogeniclength Httexon1 aggre gation by sequestering a cisacting intrinsic amphipathic activator of polyQ aggregation contained within the first 17 amino acids of Htt (N17). Our findings describe an unexpected mechanism whereby molecular chaperones alleviate Htt aggregation. Instead of simply binding the core structural element of the aggregates, TRiC inhibits a specific element that initiates aggregation. A deeper understanding of this mechanism may provide the foundation for the design of a new class of neurodegenerative disease therapies.
RESULTS

N17 domain is the primary TRiC recognition site within Htt
Reconstitution experiments show that TRiC can directly bind and sup press the aggregation of a pathogenic form of Httexon1, the naturally occurring proteolytic fragment found in HD aggregates 26, 27 . To gain insight into how TRiC modulates Htt aggregation, we used photo crosslinking to map the contacts between the chaperonin and differ ent regions in Htt ( Fig. 1 and Supplementary Fig. 1 ). Incorporation of photoactivatable probes into a protein or peptide is a wellestablished and powerful approach to identify chaperoninsubstrate binding sites 22, [28] [29] [30] . Illumination with UV light (photolysis) will activate the probe for a very short interval (nanoseconds), allowing formation of a covalent bond with proteins located in very close proximity to the probe at the time of excitation. We used the photoactivatable bifunc tional crosslinker BPIA ( Fig. 1, Supplementary Fig. 1c ) because the highly reactive benzophenone moiety of BPIA can form covalent crosslinks to proteins largely independently from the chemical nature of the binding environment. In addition, the short length of BPIA (10 Å) 31 , equivalent to an extended polypeptide chain of 3 amino acids, increases the likelihood that the crosslinks will occur only at sites that directly contact the chaperonin. We introduced unique cysteines into Httexon1 at either the N terminus, the polyQ tract or the C terminus of Httexon1 and coupled them to BPIA (Fig. 1a) . Photoactivation generated specific TRiCHtt photoadducts that were analyzed by immunoblotting with Httspecific antibodies (Fig. 1b,  top; Supplementary Fig. 1a,b) . Unexpectedly, the major TRiC dependent Htt photoadduct was obtained when the crosslinker was placed within the N17 domain ( Fig. 1a, HttA2C, and Fig. 1b , lane 2; see Fig. 1b , lane 9, for control). A weaker photoadduct was observed with the polyQ tract ( Fig. 1a, HttQ40C, and Fig. 1b , lane 4; of note, in some experiments only the N terminus was crosslinked to TRiC, see Supplementary Fig. 1b ). No TRiCdependent photoadducts were formed when the probe was placed at the C terminus ( Fig. 1a,  HttS111C and Fig. 1b , lane 6). The molecular mass of the crosslinks was consistent with monomeric Htt adducts with a single subunit, although species with higher molecular mass could also be observed ( Supplementary Fig. 1a ). These results suggest that the N17 domain is the major TRiC binding determinant within Htt.
Individual TRiC subunits differ in their substraterecognition spe cificity 19, 22 . Analysis using TRiC subunitspecific antibodies indicated that the Htt Nterminal domain crosslinks to subunit 1 (Fig. 1b, bottom) . No crosslinks were detected between subunit 1 and either the Qtract or the Cterminal domain. The interaction of subunit 1 with the N terminus of Htt may be physiologically relevant given that previous findings showed that TRiC subunit 1 suppresses by itself aggregation and toxicity of pathogeniclength Httexon1 in vivo and in vitro 19 .
Our analysis suggests that a major point of contact for TRiC within Htt resides within the Nterminal domain. To confirm this finding we examined whether purified TRiC can interact directly with N17. To this end, we incubated TRiC with a synthetic N17 peptide containing BPIA and an Nterminal biotin tag to facilitate detection and analy sis of the photoadducts. After incubation of the N17 peptide with TRiC and photolysis, efficient TRiCN17 crosslinks were formed in a crosslinker and UVdependent manner ( Fig. 1c ). This confirms that TRiC interacts directly with the Nterminal domain of Htt and demonstrates that the TRiCN17 interaction is independent of the context of the remainder of Httexon1.
The N17 domain of Htt promotes rapid polyQ aggregation
The unexpected observation that TRiC primarily contacts the Nterminal sequence element flanking the polyQ tract of Htt led us to examine whether this region plays a role in mediating Htt aggregation.
Although the relationship between polyQ tract length and aggre gation propensity has been extensively documented 3, 25, 32 , the role of the flanking sequences in the Htt aggregation process is less well understood. To directly examine whether Htt determinants outside the polyQ tract intrinsically modulate Htt aggregation, we compared the effects of various Htt domains on the in vitro aggregation rates and yields of purified Httexon1 bearing a pathogeniclength Q51 tract 16, 19, 33, 34 (Fig. 2 and Supplementary Figs. 2-5 ). Amyloid fibril formation was assessed using a previously described filtertrap assay 19 a r t i c l e s by infrared imaging ( Fig. 2a; Supplementary Figs. 2 and 3) . The contribution of the Nterminal flanking region was assessed by com paring aggregation of fulllength Httexon1 (herein HttFL; Fig. 2a ) with that of an Httexon1 variant lacking the N17 domain (Htt∆N; Fig. 2a; Supplementary Figs. 3 and 4) . Because previous studies indi cate that a PRD Cterminal to the polyQ tract attenuates Htt aggre gation and toxicity in vivo 9, 11, 12 , we also assessed whether deleting the prolinerich flanking region Cterminal to the polyQ tract had a direct effect on Htt aggregation in vitro (Htt∆P, Fig. 2a ). To cor relate our findings on Htt with previous biophysical studies focused on the aggregation propensities of polyQonly tracts, we also com pared the aggregation rates of the various Htt variants lacking any Htt flanking sequences and only bearing a polyQ tract of identical length (polyQ, Fig. 2a and Supplementary Fig. 4 ). Maximal aggregation of HttFL ( Fig. 2b) was observed after 12 h. Deleting the PRD (Htt∆P) greatly enhanced the Htt aggregation kinetics ( Fig. 2b) . Previous in vivo analyses showed that the PRD suppresses Htt aggregation and cytotoxicity in cells; these studies suggested suppression may involve recruitment of cellular factors, such as SH3 domain proteins or prolyl isomerases, to this region 9, 11, 12, 35, 36 . However, our biochemical analy sis indicates that the suppression observed in vivo can be explained by a direct effect of the PRD on the conformational equilibrium of Htt itself. Deletion of the Nterminal domain of Htt strongly delayed the kinetics of aggregation (Htt∆N; Fig. 2b ). This result suggests that the N17 domain, which contains the primary TRiC recognition site in Htt, is an endogenous intrinsic enhancer of Httexon1 aggregation. Of note, the Nterminal region of Htt accelerated aggregation but did not affect the final yield, as Htt∆N reached HttFL aggregation levels after 24 h of incubation ( Fig. 2b) . We next compared the aggregation of pathogenic Q51 Httexon1 with that of the Q51 tract without any flanking sequences (polyQ, Fig. 2a ). Strikingly, the aggregation rate of the Q51 tract was much slower than those of Httexon1 with the same polyQ tract; indeed, marked Q51 aggregation was only observed after several days of incubation ( Fig. 2b, Fig. 3c and data not shown). The aggregation rates observed for Q51 with this assay were similar to those previ ously determined for synthetic polyQ peptides 13 . It thus appears that isolated, pathogeniclength polyQ tracts aggregate with exceed ingly slow kinetics, indicating that the natural flanking sequences within the Htt protein, and perhaps other polyQexpanded proteins, play a critical role in modulating the aggregation rate.
To gain insight into the mode of action of N17 on Htt, we examined N17's ability to promote aggregation in trans. An isolated N17 peptide promoted aggregation of Htt∆N in trans ( Fig. 2c and Supplementary  Fig. 4a ). This effect was not observed upon addition of peptides bearing the scrambled N17 sequence nor with another CCT1 bind ing peptide derived from another TRiC substrate ( Supplementary  Fig. 4b ). Stoichiometric addition of N17 to Htt∆N yielded aggre gation kinetics comparable to HttFL (Fig. 2c, left; Supplementary  Fig. 4a ). Even N17 addition to HttFL itself further enhanced aggrega tion in a concentrationdependent manner ( Fig. 2c, right; Fig. 3c and Supplementary Fig. 4a ). These results indicate that the Nterminal domain is indeed a key intrinsic modulator of Htt aggregation that appears to act on a ratelimiting step leading to polyQ aggregation.
N17 interacts with two distinct Htt domains
Our finding that the isolated polyQ tract aggregates very slowly sug gests that the conformational change leading to amyloidlike fibrilli zation is a rare event promoted by the Nterminal N17 element of Htt. We hypothesized that N17 may stabilize the amyloidogenic conformer by direct interaction with specific regions within Htt (Fig. 3a) . To test this hypothesis, we mapped the interaction sites of N17 within Htt using an N17 peptide bearing the photoactivatable crosslinker BPIA and a set of GSTfused Htt variants lacking various domains. Interactions were stabilized by photolysis and analyzed by SDSPAGE and immunoblot analysis against N17 ( Fig. 3a) . N17 did not cross link to GST alone, which served as a control (Fig. 3a, lanes 1 and 6) . The distinct pattern of interactions observed for the various Htt frag ments indicated that N17 has two interaction sites within Httexon1. First, prominent photoadducts were obtained for all Htt fragments containing the N17 domain ( Fig. 3a, lanes 2 and 4) , suggesting that N17 engages in homotypic interactions with itself. Confirming this idea, N17 crosslinked directly to GST fused to the N17 domain (Fig. 3a, lane 7) , but not to GST alone (Fig. 3a, lane 6) . A second site of N17 interaction appears to be in the polyQ tract. Indeed, we found marked N17 photoadducts with the polyQ tract alone as well as minor crosslink products with the Htt fragment lacking the N17 domain (polyQ and ∆N, Fig. 3a , lanes 5 and 3, respectively).
The observation that the Nterminal element contacts two regions in Htt, itself and the polyQ tract (Fig. 3b, top) , suggests a possible mechanism by which it could stabilize an amyloidogenic conforma tion (Fig. 3b, bottom ). In this model, the interaction of N17 with the polyQ tract could serve to promote an aggregationprone conforma tion in the polyQ polymer, whereas the homotypic N17 interactions may serve to promote selfassociation of Htt molecules into oligomers The N terminus of Htt promotes rapid polyQ aggregation. (a) Htt-exon1 fragments used to analyze the contribution of individual domains toward aggregation. Formation of SDS-insoluble heat-stable aggregates was determined by filter trapping and quantified by infrared Li-Cor imaging as described in Online Methods 19, 24 (Supplementary  Figs. 2 and 3) . (b) Aggregation kinetics of Htt-exon1 fragments (Supplementary Fig. 4) . Aggregation was initiated by TEV protease addition (time = 0 h) to GST-Htt-exon1 forms. All Htt variants were efficiently cleaved by TEV protease with similar kinetics ( Supplementary  Fig. 5 ). Similar results were obtained when N17 was generated by TEV cleavage from a GST fusion (data not shown). Of note, CD and NMR indicate that N17 by itself was fully soluble at the concentrations used here (data not shown). a r t i c l e s or fibers, facilitating elongation. The idea that N17 directly promotes an amyloidogenic conformation in the polyQ tract itself predicts that N17 addition to an isolated Q51 tract should stimulate aggregation. Indeed, as observed for Htt FL, trans addition of N17 peptide stimu lated aggregation of the isolated polyQ tract as well as all constructs containing the polyQ region ( Fig. 3c and data not shown) .
An amphipathic region within N17 promotes Htt aggregation
Next, we examined in more detail the structural properties of the N17 domain. The AGADIR algorithm 37 indicated that amino acids 4-12 within N17 have αhelix propensity, consistent with previous circular dichroism measurements 38 . Projection of this sequence onto a helical wheel revealed the amphipathic nature of the helix (Fig. 4a, left) . We found that conservation of the helical character in this Nterminal element is important for promoting polyQ aggregation, as introduc ing two helixbreaking (HB) prolines at positions 7 and 9 within the intact Httexon1 (Fig. 4a , right) strongly blocked aggregation even after prolonged incubation (Fig. 4b) . Furthermore, replacing the natural Htt sequence with a polyalanine helix (AA: all alanine) also blocked aggregation (Fig. 4b) , indicating that specific determinants within the N17 helix stabilize the amyloidogenic Htt conformation.
We then examined the contribution of the amphipathic nature of N17 to aggregation (Fig. 4b) . Alanine replacement of the polar resi dues (HttPA: polar to alanine) reduced the maximal Htt aggregation yield to ~50% of that of HttFL. Notably, replacing the hydrophobic face with alanines (HttNA: nonpolar to alanine) completely abro gated Htt aggregation (Fig. 4b) . An outcome from this analysis is that mutations blocking the N17 hydrophobic surface (HB, AA and NA, Fig. 4b ) markedly impaired aggregation, whereas deletion of the entire N17 only slowed this process (Fig. 2b) . This is underscored by directly comparing the aggregation kinetics of Htt bearing the N17 helix mutants with those of Htt∆N or a polyQ tract of identical length (Fig. 4c) . Blocking the hydrophobic surface of N17 suppressed aggregation to levels even below those of isolated polyQ ( Fig. 4c ; note logarithmic scale). Furthermore, disruption of the hydrophobic face of N17 rendered Htt refractory to the aggregation enhancing activity of added N17 peptide (Supplementary Fig. 6) . It thus appears that a cisacting block of the hydrophobic surface of N17 is dominant over the effect of trans activators of aggregation.
The marked effect of blocking the hydrophobic surface of N17 on Htt aggregation was also observed in vivo upon expression of GFP tagged Httexon1 Q103 variants in HeLa cells (Fig. 4d) . As expected, Htt ) as α-helical, which are projected as a helical wheel to illustrate its amphipathic nature (above). Schematic representation of helical variants of Htt-exon1 analyzed for effects on aggregation (below). (b) Aggregation kinetics of Htt-exon1 bearing the indicated N-terminal helix variants assessed as in Figure 2b . The mutants did not affect the efficiency of TEV protease-mediated cleavage (Supplementary Fig. 5 ). a r t i c l e s HttQ103 aggregated, whereas the nonpathogenic Q23 variants remained soluble and diffuse. Deletion of the N17 region resulted in a reproducible reduction in the number of cells bearing aggregates, as expected from its lower aggregation kinetics in vitro (Fig. 4d) . Notably, disruption of the N17 hydrophobic determinant by the NA or AA mutation completely abrogated Htt aggregation, despite expression of a Htt form containing a 103residuelong Qtract. We conclude that rapid Htt aggregation is critically dependent on the hydrophobic surface of the amphipathic N17 helix.
In sum, blocking the hydrophobic face of the N17 helix has a dominant negative effect on aggregation both in vitro and in vivo. We propose that the mutated NAN17 helix sterically hinders the oligomerization events leading to aggregation, whereas the absence of the N terminus allows the formation of a new polyQpolyQ interface between βsheet monomers, albeit at a slower rate.
TRiC sequesters the hydrophobic surface of Htt-N17
Our experiments revealed that the N17 domain, which contains the major Htt binding site for TRiC, played a key role directly promoting efficient Htt aggregation. Furthermore, our N17 analysis showed that blocking the hydrophobic face of this amphipathic helix had a dominant negative effect of Htt aggregation. Given the preference of chaperones for hydro phobic recognition determinants 39 , we considered whether TRiC inhibits Htt aggregation through interaction with the hydrophobic face of N17. We tested directly the effect of disrupting the hydrophobic surface of N17 on its interaction with TRiC. Whereas an N17 peptide bearing the wildtype sequence (N17WT) efficiently crosslinked to TRiC (Fig. 1c  and Fig. 5a) , introducing N17NA greatly reduced interaction with TRiC, indicating that the hydrophobic residues are indeed required for TRiC binding (Fig. 5a; Supplementary Fig. 7) . This conclusion was supported by wholecell extract TRiC association experiments using either N17WT or N17NA Httexon1 (Supplementary Fig. 8) . Although WT Htt exon1 associates with TRiC upon incubation with yeast or mammalian cell extracts as described 19 , this interaction was abrogated by the N17NA mutation in Httexon1 (Supplementary Fig. 8 for yeast extracts; data not shown for mammalian lysates).
Previous in vivo experiments indicated that overexpression of TRiC subunit 1 can suppress aggregation and toxicity of Httexon1 (ref. 19 ). Furthermore, the purified substratebinding domain of subunit 1 (Apical 1) alone can suppress Httexon1 aggregation in vitro 19 . In contrast, other TRiC subunits, such as subunit 3 (also called CCT3), did not affect Htt aggregation either in vivo or in vitro 19 , indicating that TRiC subunit 1 contains a major chaperonin binding site for Htt. Intriguingly, our analysis of Htt crosslinks with intact TRiC (Fig. 1 ) also implicated subunit 1 as a major contact site within TRiC for the Htt N terminus (Fig. 1b, bottom) . We next tested whether TRiC suppresses Htt aggregation through the interaction of subunit 1 with the hydrophobic surface of helix N17. Indeed, isolated Apical 1 domain efficiently crosslinked to the isolated N17 domain with the wildtype sequence (N17WT, Fig. 5b) . In contrast Apical 1 did not interact with an N17 domain containing a disrupted hydrophobic face (Fig. 5b, lanes 1 and 2) . Interaction with N17 was TRiCsubunit specific, as the apical domain of subunit 3 (Apical 3) showed no detectable crosslinks with either N17 peptide (Fig. 5b, lanes 3 and 4) . Thus, the substratebinding domain of TRiC subunit 1 interacts directly with the hydrophobic face of the N17 helix. We next exam ined whether both TRiC or Apical 1 can neutralize the aggregation promoting action of N17. To this end, either chaperonin was added to the transactivation assay in which N17 stimulates Htt∆N aggrega tion (Fig. 5c) . Both TRiC and Apical 1 dramatically suppressed the aggregation promoting effect of N17 addition (Fig. 5c) .
DISCUSSION
Here we define the mechanism by which the chaperonin TRiC sup presses Htt aggregation. Our results do not support the simple model in which the chaperonin directly sequesters the aggregationprone polyQ tract but instead indicate that TRiC acts primarily by blocking a short amphipathic Htt sequence element that promotes aggrega tion. Our analysis suggests a resolution for the conundrum of how chaperonins, which recognize hydrophobic determinants, can sup press aggregation of the polar polyQ tract. Furthermore, our finding that aggregation of isolated polyQ tracts occurs very slowly and is strongly accelerated by an endogenous flanking region in Httexon1 has important implications for understanding and treatment of polyQ diseases.
Htt conformational equilibrium is modulated by N17 domain
The correlation between polyQ tract length and disease severity has led to the concept that positive regulation of polyQ aggregation kinet ics is solely a function of polyQ repeat length. Our understanding of HD must include the critical contribution of the N17 amphipathic helix, which we demonstrate promotes rapid Htt aggregation by direct modulation of Htt conformation (Fig. 6a) . The N17 domain is highly conserved across species and was previously implicated in Htt trafficking in vivo 40 and in promoting membrane association of native Htt 41 . Thus, the cellular function of Htt may maintain this aggregationpromoting element despite its potential to disrupt protein homeostasis.
PolyQ aggregation and cytotoxicity are thought to arise from a conformational transition whereby a polyQ protein monomer a r t i c l e s switches from a nontoxic extended αhelical conformation to a more compact toxic βsheet conformation that assembles into amyloidlike fibrils 26, 34, 42 (Fig. 6b) . Our finding that a pathogenic length polyQ tract aggregates exceedingly slowly ( Fig. 2b and Fig. 3c ) indicates that the polyQ tract only rarely switches to the amyloidogenic conforma tion. For Htt, this conformational equilibrium is directly regulated by sequence elements outside the polyQ tract ( Fig. 6a) . It is likely that the PRD, which slows aggregation, stabilizes the nonamyloidogenic conformation ( Fig. 6b) 13 . Our data comparing the aggregation kine tics of various Htt variants also suggest that the C terminus of Htt exon1 also plays a yettobedefined role in the aggregation process ( Fig. 2 and data not shown) . The N17 aggregationpromoting element is likely to accelerate the ratelimiting conformational switch to the amyloidogenic conformation ( Fig. 6b) .
How does N17 promote the amyloidogenic conformation? We found that N17 interacts with itself and the polyQ tract ( Fig. 3) . We propose that these interactions trigger the initial conformational switch to the βsheet conformation and facilitate selfassembly and incorporation into fibrils (Fig. 6b) . Our model is consistent with the proposed molecular architecture of amyloid fibrils, in which amyloidogenic monomers are thought to polymerize in a headto head and tailtotail fashion 6, 43 . Our model is also supported by the observed in vivo effects of N17 on Htt aggregation (Fig. 4d) 11, 40 . Furthermore, our results provide a mechanistic explanation for the suppression of Htt aggregation using N17 region-specific anti bodies 44 . Recently, Thakur et al. used Httexon1-like peptides to demonstrate that an expanded polyQ tract induces N17 unfolding and subsequent homooligomerization with neighboring Httexon1 N17 regions 45 . Although this work was carried out with synthetic peptides rather than the entire Httexon1 sequence, these findings are consistent with our model, in which homotypic N17N17 and polyQ polyQ interactions contribute to rapid polyQ aggregation through stabilization of an amyloidogenic conformation. A scenario in which the Nterminal helix mediates headtohead interactions could also explain why the N17NA mutation inhibits aggregation in a domi nant negative manner, beyond what is observed for Htt∆N or even for the polyQ tract itself; thus, our model would predict the blocked N17 helix inhibits new polyQpolyQ interactions. Our results explain how TRiC binding to this region could effectively block aggregation of even very long polyQ tracts.
TRiC curbs Htt aggregation by blocking an amyloidogenic switch
Our identification of the hydrophobic face of N17 as both being criti cal for Htt aggregation and being the major TRiCbinding determinant within Htt suggests an unexpected mechanism for how the chaperonin can prevent Htt aggregation. Because blocking the hydrophobic face of N17 strongly inhibits Htt aggregation to levels below those observed for polyQ only, it is likely that TRiC binding to this element acts similarly to the N17NA mutations. This model can explain previous observations that TRiC potently inhibits Htt aggregation at an early step and at substoichiometric ratios [17] [18] [19] . TRiC binding to N17 would both stabilize the monomeric nontoxic conformation and impose a large steric 'cap' on the polyQ oligomers that prevent fibril formation (Fig. 6b) . Because TRiC also crosslinks weakly to the polyQ tract, additional TRiCpolyQ contacts could further modulate aggregation, perhaps through interaction with TRiC subunits other than subunit 1. Of note, the photocrosslinking assay detects soluble and largely nonamyloidogenic Htt molecules, and thus failure to detect strong TRiCpolyQ interactions might be due to TRiC binding preferentially to the amyloidogenic conformation of polyQ. Nonetheless, we find that TRiC prevents aggregation of fulllength Httexon1 much more effectively than aggregation of polyQ only (Supplementary Fig. 9 ), supporting the notion that the presence of N17 is key for efficient TRiCmediated suppression of aggregation. Taken as a whole, our study indicates that molecular chaperones can modulate formation of toxic aggregates by interacting with short sequence elements that regulate the amyloidogenic conformational transition rather than just by sequestration of the polyQ tract alone.
Implications for other polyQ-linked diseases
Given that polyQ itself aggregates much more slowly than Htt with an equivalent polyQ length ( Fig. 2b and Fig. 3c) , it is tempting to specu late that N17like aggregationpromoting elements also contribute to aggregation of other diseasecausing pathogenic polyQ proteins. Because N17 can promote Htt aggregation even when added in trans, the aggregationpromoting elements need not be physically linked to the N terminus of the polyQ tract. This finding raises the possibil ity that elements acting similarly to N17 also exist for other polyQ proteins, but that they might be located in different regions of the polyQ protein or even in an interaction partner. Furthermore, such aggregationpromoting elements for different pathogenic polyQ pro teins could be regulated by different sets of chaperones. As a result, the balance between individual aggregationpromoting elements and specific chaperone interactions would vary for different polyQ containing proteins, perhaps accounting in part for the variations in age of onset, tissue specificity and clinical course observed for polyQ Figure 6 Htt polyQ aggregation is controlled by the interplay of positive and negative regulatory sequence elements together with the chaperone machinery. (a) Control of polyQ aggregation in Htt. The PRD attenuates polyQ aggregation propensity, while the N-terminal region (N) promotes the amyloid conformation. In turn, the chaperonin TRiC counteracts the positive effect of the N region, thereby suppressing aggregate formation. (b) Proposed model for the molecular events regulating Htt conformation. The polyQ domain in the Htt monomer populates predominantly a helical, nonamyloidogenic conformation likely stabilized by the PRD 42 . The amphipathic N-terminal helix of Htt-exon1 interacts with both the polyQ region and itself. N17-polyQ interactions likely stabilize the amyloidogenic β-sheet conformation. Homotypic N-terminal interactions may facilitate intermolecular contacts linking amyloidogenic species to higher-ordered structures. TRiC sequesters N17 by binding the hydrophobic side of the N17 helix, thus blocking amyloid formation and growth. a r t i c l e s diseases 16 . Our findings illustrate the emerging concept that cellular protein homeostasis is controlled by the interplay of cellular chap erones and defined elements within proteins 46, 47 . The idea that such interactions play an important regulatory role beyond polypeptide folding has important implications for a large number of human pathologies, including aging and neurodegeneration.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
